[AsCNP_S29] シンポジウム29
Research on Asian Psychotropic prescription pattern ( REAP )

2019年10月12日(土) 10:30 〜 12:10 第14会場 (パレスルームA)

Organizer / Chair: Shih-Ku LIN (Taipei City Hospital and Psychiatric Center, Taiwan), Discussants: ‌Chay Hoon TAN (National University of Singapore, Singapore), Andi Jayalangkara TANRA (Universitas Hasanuddin, Indonesia)

REAP is the longest standing and the largest international collaborating research in the field of psychiatry in Asia. The study started in 1999 as a large scale collaborative research project in East Asia. The REAP studied the prescription of patients with schizophrenia in 2001, 2004, 2008 and 2016. Fifteen countries and areas in Asia participated in the REAP survey in 2016. More than seventy papers were published from this consortium.
The first survey of bipolar disorder is implemented in 2018. In this symposium, Prof Shinfuku will give an overview talk on REAP and its clinical implication and influence; Prof Inada will discuss the use of Dug-induced Extrapyramidal Symptoms Scale in REAP AP4; Prof Chong will discuss multiple versus single antipsychotic drug treatment of inpatients with schizophrenia; and Prof Lin will report the findings from REAP Bipolar disorder.

+全てマイスケジュールに登録

10:30 〜 10:35

[AsCNP-S29-Introduction] Introduction

^○Mian-Yoon CHONG^{1, 2} (1. Chang Gung Memorial Hospital, ChiaYi, Taiwan, 2. Chang Gung University School of Medicine, Taiwan)

10:35 〜 10:55

[AsCNP-S29-1] High dose prescription and polypharmacy for persons with schizophrenia in Japan-Findings from 4 REAP surveys on the prescription of psychotropic drugs from 2001-to 2016

^○Naotaka SHINFUKU (Kobe University, Kobe, Japan)

10:55 〜 11:15

[AsCNP-S29-2] Profiles of antipsychotic-induced extrapyramidal symptoms assessed using the DIEPSS in 5 Asian countries attending the REAP AP4 survey

^○Toshiya INADA¹, Chika KUBOTA², Ajit AVASTHI³, Kok-Yoon CHEE⁴, Andi Jayalangkara TANRA⁵, Shin-Ku LIN⁶, Naotaka SHINFUKU⁷ (1. Department of Psychiatry and Psychobiology, Nagoya University Graduate School of Medicine, Aichi, Japan, 2. National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan, 3. Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India, 4. Department of Psychiatry & Mental Health, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia, 5. Department of Psychiatry, Hasanuddin University, Makassar, Indonesia, 6. Department of Psychiatry, Taipei City Hospital and Psychiatric Center, Taipei, Taiwan, 7. Emeritus Professor, Kobe University, Kobe, Japan)

11:15 〜 11:35

[AsCNP-S29-3] Multiple versus single antipsychotic drug treatment of inpatients with schizophrenia in Asia

^○Mian-Yoon CHONG^{1, 2} (1. Chang Gung Memorial Hospital, ChiaYi, Taiwan, 2. Chang Gung University School of Medicine, Taiwan)

11:35 〜 11:55

[AsCNP-S29-4] Polypharmacy in Bipolar disorder: Findings from REAP Bipolar Disorder

^○Shih-Ku LIN^{1, 2}, Shu-Yu YANG¹, Naotaka SHINFUKU ³ (1. Taipei City Hospital and Psychiatric Center, Taiwan, 2. School of Medicine, Taipei Medical University, Taiwan, 3. Kobe University School of Medicine, Japan)

11:55 〜 12:05

[AsCNP-S29-Discussion] Discussion

12:05 〜 12:10

[AsCNP-S29-Conclusion] Conclusion